Mirum Pharma Insider Buy Boosts Investor Optimism Amid Rising Stock
Mirum Pharmaceuticals insider buy signals confidence amid 104% year‑to‑date rally and growing liver‑disease pipeline—what it means for investors.
2 minutes to read
MIRUM PHARMACEUTICALS INC
Mirum Insider Moves Signal Bullish Outlook Amid FDA Fast‑Track and New Therapeutics
Mirum insider moves reveal strategic confidence: Saira buys low, sells high while keeping long‑term stake, amid fast‑track FXR drug progress and promising NASH results.
4 minutes to read